Skip to main content

DNA integrity in plasma and serum of patients with malignant and benign diseases.

Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P

Publication: Ann N Y Acad Sci (2008) • Vol 1137 • Page 162-70PMID: 18837942View on PubMed

Purpose

The purpose of this paper was to compare cell-free DNA concentrations and integrity indices between serum and plasma and between specimens from cancer patients and patients with benign diseases.

Conclusion

DNA concentrations measured by real time qPCR were higher among serum specimens than plasma specimens, regardless of diagnosis, and no correlation was seen between DNA concentrations or DNA integrity indices in serum and plasma. There were no significant differences between DNA concentrations or median DNA integrity indices in specimens from cancer patients and those with benign disease.

Studies (1)

Purpose

The purpose of this study was to compare cell-free DNA concentrations and integrity indices between serum and plasma and between specimens from cancer patients and patients with benign diseases.

Summary of Findings

DNA concentrations measured by real time qPCR were higher among serum specimens than plasma specimens, regardless of diagnosis, and no correlation was seen between DNA concentrations or DNA integrity indices in serum and plasma. There were no significant differences between DNA concentrations in plasma from cancer patients and those with benign disease or between DNA concentrations in serum from cancer patients and those with benign disease. Without taking into account the specimen type, the median DNA integrity indices were also not significantly different between patient groups. The authors state that for serum and plasma, neither DNA concentration nor DNA integrity index was correlated with tumor characteristics such as size, stage, lymph node status, or the presence of metastasis.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    NeoplasticBenign
    NeoplasticCarcinoma
  • Platforms

    DNAReal-time qPCR
    DNAPCR
    DNAElectrophoresis
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Benign disease
    Cancer
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum